UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003961
Receipt number R000004771
Scientific Title XELOX(+bevacizumab), efficacy, safety, QOL Study:FOLFOX(+bevacizumab) after starting therapy, for patients can't continue continuous infusion therapy
Date of disclosure of the study information 2010/07/28
Last modified on 2011/08/01 11:55:02

No. Disposal Last modified on Item of update
1 Insert 2010/07/28 11:48:55
2 Update 2011/08/01 11:52:35 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2011/08/01 11:55:02 Recruitment status